| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |